WillsEye Hospital

Philadelphia, Pennsylvania 19123

9 studies enrolling now · 70 studies all time

What they study most

Acute Conjunctivitis, Adenoviral Conjunctivitis, Amblyopia, Astigmatism, Blepharospasm, Cataract, Choroidal Melanoma, Conjunctival Malignant Melanoma, DME, Diabetic Macular Edema, Diabetic Macular Edema (DME), Diabetic Retinopathy

Studies at this site

• CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME — Recruiting now
• Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy — Recruiting now
• Neoadjuvant Tebentafusp for Uveal Melanoma — Recruiting now
• Descemet Endothelial Thickness Comparison Trial II — Recruiting now
• Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age — Recruiting now
• Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age — Recruiting now
• A Randomized Trial to Evaluate Sequential vs Simultaneous Patching — Recruiting now
• Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma — Recruiting now
• Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
• Novel Glaucoma Diagnostics — Recruiting now
• Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus — Completed
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema — Completed
• A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema — Running, not enrolling
• A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma — Running, not enrolling
• An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED) — Running, not enrolling
• Descemet Endothelial Thickness Comparison Trial I — Running, not enrolling
• Electrical Stimulation for the Treatment of Glaucoma — Running, not enrolling
• CNGB1 and Allied Disorders — Paused
• Evaluating Home Testing Devices for the Management of Glaucoma — Completed
• Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma — Stopped early
• An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED) (THRIVE-2) — Completed
• Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3) — Stopped early
• Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-1) — Stopped early
• Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma — Completed
• RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD) — Completed
• Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients — Completed
• A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. — Stopped early
• Study in Subjects With Small Primary Choroidal Melanoma — Completed
• Comparison Study of Glaucoma Eye Care Follow-Up Adherence in a High Risk Population — Completed
• Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• visuALL Field Analyzer (vFA) Compared to Standard Humphrey Automated Perimetry — Completed
• Intravitreal Aflibercept for the Prevention of Proliferative Vitreoretinopathy Following Retinal Detachment Repair — Status unconfirmed
• Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries — Status unconfirmed
• Argus® II Retinal Stimulation System Feasibility Protocol — Completed
• The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS) — Stopped early
• Anesthetic Impregnated Bandage Soft Contact Lens (BSCL) in Pain Management After Photorefractive Keratectomy (PRK) — Status unconfirmed
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO — Stopped early
• IOP and Medication Reduction in MIGS Procedures — Withdrawn before enrolling
• Efficacy & Safety of RPh201 Treatment in Patients With Previous Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) — Stopped early
• Transcorneal Electrical Stimulation (TES) for the Treatment of Amblyopia — Status unconfirmed
• Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment — Completed
• Electric Stimulation of the Eye to Improve Vision After Trauma — Completed
• Interest in Electronic Applications for Patients With Glaucoma — Completed
• Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm — Completed
• RETINA IMPLANT Alpha AMS in Blind Patients With Retinitis Pigmentosa — Withdrawn before enrolling
• Collaborative Care for Depression and Diabetic Retinopathy in African Americans — Completed
• Does Using a Low Vision Aid Device Improve Quality of Life in Glaucoma Patients? — Completed
• Normative Database for Pattern Electroretinogram (PERG) and Flash Electroretinogram (FERG) — Completed
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial — Completed
• Topical Ophthalmic AGN-195263 for the Treatment of Evaporative Dry Eye — Stopped early